Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-010845
Filing Date
2026-03-18
Accepted
2026-03-18 07:45:51
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6917
  Complete submission text file 0001493152-26-010845.txt   8412
Mailing Address JOHNS HOPKINS UNIVERSITY 720 RUTLAND AVENUE BALTIMORE MD 21205
Business Address
SIDRANSKY DAVID (Reporting) CIK: 0001277161 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36345 | Film No.: 26765365

Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608
Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448
Galmed Pharmaceuticals Ltd. (Issuer) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)